Taiwan · Delayed Price · Currency is TWD Anxo Pharmaceutical Statistics
Total Valuation
TPEX:6677 has a market cap or net worth of TWD 893.94 million. The enterprise value is 1.42 billion.
| Market Cap | 893.94M |
| Enterprise Value | 1.42B |
Important Dates
The next estimated earnings date is Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6677 has 55.87 million shares outstanding. The number of shares has decreased by -1.48% in one year.
| Current Share Class | 55.87M |
| Shares Outstanding | 55.87M |
| Shares Change (YoY) | -1.48% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 4.39% |
| Owned by Institutions (%) | 9.53% |
| Float | 27.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| PB Ratio | 0.81 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.08 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | 28.02 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.45, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.45 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | 14.68 |
| Debt / FCF | -30.41 |
| Interest Coverage | -1.56 |
Financial Efficiency
Return on equity (ROE) is -1.99% and return on invested capital (ROIC) is -1.70%.
| Return on Equity (ROE) | -1.99% |
| Return on Assets (ROA) | -0.78% |
| Return on Invested Capital (ROIC) | -1.70% |
| Return on Capital Employed (ROCE) | -1.72% |
| Weighted Average Cost of Capital (WACC) | 4.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | -6.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.57% in the last 52 weeks. The beta is 0.30, so TPEX:6677's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -20.57% |
| 50-Day Moving Average | 16.66 |
| 200-Day Moving Average | 19.41 |
| Relative Strength Index (RSI) | 41.82 |
| Average Volume (20 Days) | 29,141 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6677 had revenue of TWD 878.88 million and -20.46 million in losses. Loss per share was -0.37.
| Revenue | 878.88M |
| Gross Profit | 323.15M |
| Operating Income | -25.65M |
| Pretax Income | -28.31M |
| Net Income | -20.46M |
| EBITDA | 36.35M |
| EBIT | -25.65M |
| Loss Per Share | -0.37 |
Balance Sheet
The company has 334.82 million in cash and 741.46 million in debt, with a net cash position of -406.64 million or -7.28 per share.
| Cash & Cash Equivalents | 334.82M |
| Total Debt | 741.46M |
| Net Cash | -406.64M |
| Net Cash Per Share | -7.28 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 17.96 |
| Working Capital | 260.81M |
Cash Flow
In the last 12 months, operating cash flow was 55.59 million and capital expenditures -79.97 million, giving a free cash flow of -24.38 million.
| Operating Cash Flow | 55.59M |
| Capital Expenditures | -79.97M |
| Depreciation & Amortization | 62.00M |
| Net Borrowing | 18.42M |
| Free Cash Flow | -24.38M |
| FCF Per Share | -0.44 |
Margins
Gross margin is 36.77%, with operating and profit margins of -2.92% and -2.33%.
| Gross Margin | 36.77% |
| Operating Margin | -2.92% |
| Pretax Margin | -3.22% |
| Profit Margin | -2.33% |
| EBITDA Margin | 4.14% |
| EBIT Margin | -2.92% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6677 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.48% |
| Shareholder Yield | 1.48% |
| Earnings Yield | -2.29% |
| FCF Yield | -2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 1, 2021. It was a forward split with a ratio of 1.05.
| Last Split Date | Nov 1, 2021 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |